Comparison Chart Harrow, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 17:59:48 15/05/2024 BST			5-day change	1st Jan Change
16.92 ^USD	+4.16%		+62.50%	+49.73%

02:11pm	B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating	MT
05-14	Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	HARROW, INC.	Other Pharmaceuticals	+3.33%	+62.50%	+49.73%	-19.72%	+193.18%	575M